NCT00820807

Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes

Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes: a Randomized, Placebo-controlled, Double-blind, Parallel Group Clinical Trial

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Cargill · Industry
• Sex: All
• Age: 30 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study will critically evaluate the effects of a novel dietary fiber administered to subjects at high risk for developing diabetes to determine if this intervention will improve insulin sensitivity compared to control product administration and, thus, decrease risk for developing diabetes. The hypothesis is that consuming this novel fiber twice a day for 12 weeks will significantly decrease fasting plasma glucose, insulin and glycosylated hemoglobin values in pre-diabetic subjects (i.e. subjects with fasting plasma glucose levels 95-140 mg/dl at screening) compared to consumption of the control product.

Conditions

• Insulin Resistance

Interventions

Type	Name	Description
OTHER	Novel dietary fiber	oral consumption in beverage
OTHER	Novel dietary fiber	oral consumption in beverage
OTHER	Placebo	oral consumption in beverage

Timeline

• Start date: 2009-01-01
• Primary completion: 2009-06-01
• Completion: 2009-06-01
• First posted: 2009-01-12
• Last updated: 2011-06-17

Locations

1 site across 1 country: United States